Deputy Director of the Center for Clinical Affairs Mykhailo LOBAS and Director of the Health Technology Assessment Department Oresta PINIAZHKO took part in the World Congress on Evidence, Pricing, and Access in Healthcare (World EPA Congress 2024), the largest congress in Europe on market access, pricing, and evidence. The event took place on 12-13 March in Amsterdam (the Netherlands).
As part of the event, our specialists took part in a number of plenary sessions and sessions devoted to real-world evidence, the conduct of clinical trials of medicinal products, patient access to new treatments, managed entry agreements, the use of data in the HTA process, market access and pricing, and also digitalization in healthcare.
As a speaker, Oresta PINIAZHKO gave a presentation, “Access to innovative health technologies in Ukraine and Central and Eastern Europe” (“Access to innovative health technologies in Ukraine and CEE”).
The event brought together representatives of HTA agencies from leading European countries, international healthcare experts, and representatives of the pharmaceutical and biotechnology industries.
Our global goals for participating in the Congress:
- to exchange experience and strengthen ties with representatives of the international community on HTA, clinical trials and pricing;
- to become familiar with global perspectives on market access and pricing, digital transformation (data analytics), the use of data for HTA, innovative economic processes in healthcare, and new EU regulatory requirements for HTA and clinical trials.
- present Ukraine's experience, raise the level of compliance of HTA procedures in Ukraine with international practice.
Studying international experience will contribute to improving the Center’s work toward ensuring the population’s access to clinically effective and cost-effective medicinal products.
